Laboratorios de Biologicos y Reactivos de México, S.A. de C.V. Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Mexico City Mexico

Organization Overview

First Clinical Trial
2008
NCT00739440
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

Laboratorios de Biológicos y Reactivos de México S.A de C.V

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Influenza, Human (Phase 3)

Poliomyelitis (Phase 3)

Scorpion Stings (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 5